<table className="table">
  <caption><p>
    Clinical Manifestations, Diagnostic Testing, and Treatment of Lyme Disease by Stage of Infection</p>
  </caption>
  <thead>
    <tr>
      <th rowSpan="1" colSpan="1"><p>
        Lyme Stage</p>
      </th>
      <th rowSpan="1" colSpan="1"><p>
        Onset after Infection</p>
      </th>
      <th rowSpan="1" colSpan="1"><p>
        Clinical Findings</p>
      </th>
      <th rowSpan="1" colSpan="1"><p>
        Laboratory Confirmation</p>
      </th>
      <th rowSpan="1" colSpan="1"><p>
        Treatment<sup>
        a,b</sup></p>
      </th>
    </tr>
  </thead>
  <tbody>
    <tr className="group_1-1 row-odd">
      <td rowSpan="1" colSpan="1"><p>
        Early localized</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        ≤4 wk</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        EM at site of tick attachment; variably with fever, lymphadenopathy, myalgia</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Not needed if EM present</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Doxycycline, 100 mg PO BID × 10 d (first-line therapy)</p><p><i>
        or</i></p><p>
        Amoxicillin, 500 mg PO TID × 14 d</p><p><i>
        or</i></p><p>
        Cefuroxime axetil, 500 mg PO BID × 14 d</p>
      </td>
    </tr>
    <tr className="group_1-2 row-even">
      <td rowSpan="1" colSpan="1"><p>
        Early disseminated</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        2 wk-6 mo</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Constitutional: Multiple sites of EM, flu-like syndrome</p><p>
        Cardiac: heart block, myocarditis</p><p>
        Neurologic: cranial neuropathies, meningitis, radiculitis, mononeuritis multiplex, spinal cord or brain parenchymal inflammation</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Not needed if EM is present; otherwise, two-tier serologic testing</p><p>
        CSF evaluation when CNS involvement is a concern<sup>
        c</sup></p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        1. Cardiac</p><p>
        Hospitalized patients (first-degree AV block with PR interval ≥300 msec, higher degree heart block, other arrhythmias, myopericarditis): initial IV ceftriaxone with transition to oral for total of 14-21 d</p><p>
        Outpatients (first-degree AV block with PR interval &lt;300 msec): oral treatment same as for early localized disease × 14-21 d</p><p>
        2. Meningitis/radiculoneuropathy: IV ceftriaxone or oral doxycycline × 14-21 d<sup>
        d</sup>
        (IV antibiotics preferred for spinal or brain parenchymal involvement)</p><p>
        3. Other manifestations (including facial palsy): oral treatment the same as for early localized disease × 14-21 d</p>
      </td>
    </tr>
    <tr className="group_1-3 row-odd">
      <td rowSpan="1" colSpan="1"><p>
        Late disseminated</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        ≥6 mo</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Arthritis; neurologic symptoms (peripheral neuropathy, encephalopathy)</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Two-tier serologic testing</p><p>
        Synovial fluid PCR in seropositive persons when Lyme arthritis is a diagnostic consideration</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Initial Lyme arthritis treatment is same as for early localized but × 28 d<sup>
        e</sup></p><p>
        Arthritis unresponsive to initial treatment: IV ceftriaxone 2-4 weeks</p>
      </td>
    </tr>
  </tbody>
</table>